Cited by 390Epigenetics and DNA MethylationGenomics and Chromatin DynamicsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 765 of the 770 references it cites were found in a registry or an index.

The epigenetics of aging and neurodegeneration

Open access

Lardenoije, Roy, Iatrou, Artemis, Kenis, Gunter, Kompotis, Konstantinos, Steinbusch, Harry W.M., Mastroeni, Diego, Coleman, Paul, Lemere, Cynthia A., Hof, Patrick R., van den Hove, Daniel L.A., Rutten, Bart P.F.·2015·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2015.05.002PMC PMC6477921

Open this paper in CoChat — free account

Abstract

Epigenetics is a quickly growing field encompassing mechanisms regulating gene expression that do not involve changes in the genotype. Epigenetics is of increasing relevance to neuroscience, with epigenetic mechanisms being implicated in brain development and neuronal differentiation, as well as in more dynamic processes related to cognition. Epigenetic regulation covers multiple levels of gene expression; from direct modifications of the DNA and histone tails, regulating the level of transcription, to interactions with messenger RNAs, regulating the level of translation. Importantly, epigenetic dysregulation currently garners much attention as a pivotal player in aging and age-related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, where it may mediate interactions between genetic and environmental risk factors, or directly interact with disease-specific pathological factors. We review current knowledge about the major epigenetic mechanisms, including DNA methylation and DNA demethylation, chromatin remodeling and non-coding RNAs, as well as the involvement of these mechanisms in normal aging and in the pathophysiology of the most common neurodegenerative diseases. Additionally, we examine the current state of epigenetics-based therapeutic strategies for these diseases, which either aim to restore the epigenetic homeostasis or skew it to a favorable direction to counter disease pathology. Finally, methodological challenges of epigenetic investigations and future perspectives are discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2015.05.002

Cites

765 of 765 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

4 retracted

RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Dönmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 443
Retracted
RETRACTED: Directed Conversion of Alzheimer's Disease Patient Skin Fibroblasts into Functional Neurons
Liang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 231
Retracted
KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling
Kaidi, A., & Jackson, S. P. (2013) · Nature · doi:10.1038/nature12201 · Cited by 167
Retracted
Chromosome 21-derived MicroRNAs Provide an Etiological Basis for Aberrant Protein Expression in Human Down Syndrome Brains
Kuhn, D. E., Nuovo, G. J., Terry, A. V., Martin, M. M., Malana, G. E., Sansom, S. E., Pleister, A. P., Beck, W. D., Head, E., Feldman, D. S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033407 · Cited by 121
Retracted
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728

Show all 770 references

Research works printed but not linked: 2

Alarcón, 2004, Chromatin acetylation, memory, and LTP are impaired in CBP+/− mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration, Neuron, 42, 947, 10.1016/j.neuron.2004.05.021 · DOI · Paper page
Lovestone, 1997, The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience, 78, 309

Sorted by citations

Items 101–200 of 390

Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics
Pisanu, C., Papadima, E. M., Zompo, M. D., & Squassina, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.06.045 · Cited by 45
Genetic background, epigenetic factors and dietary interventions which influence human longevity
Costa, D., Scognamiglio, M., Fiorito, C., Benincasa, G., & Claudio Napoli, A. (2019) · Biogerontology · doi:10.1007/s10522-019-09824-3 · Cited by 47
Epigenetic Mechanisms of Learning and Memory: Implications for Aging
Creighton, S. D., Stefanelli, G., Reda, A. J., & Zovkic, I. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186918 · Cited by 45
Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease
Lardenoije, R., van den Hove, D., Havermans, M., van Casteren, A., Le, K. X., Palmour, R., Lemere, C. A., & Rutten, B. P. F. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.11.002 · Cited by 42
Self-citation
Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission
Yeo, M., Chen, Y., Jiang, C., Chen, G., Wang, K., Chandra, S., Bortsov, A. V., Lioudyno, M., Zeng, Q., Wang, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26270-3 · Cited by 42
Epigenetic Mechanisms of the Aging Human Retina
Pennington, K. L., & DeAngelis, M. M. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25513 · Cited by 42
Coarse-Grained Models to Study Protein–DNA Interactions and Liquid–Liquid Phase Separation
Kapoor, U., Kim, Y. C., & Mittal, J. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00525 · Cited by 34
Aging-related 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurochemial and behavioral deficits and redox dysfunction: improvement by AK-7
Guan, Q., Wang, M., Chen, H.-Q., Yang, L., Yan, Z., & Wang, X. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.011 · Cited by 39
Neurodegenerative movement disorders: An epigenetics perspective and promise for the future
Murthy, M. N., Cheng, Y. Y., Holton, J. L., & Bettencourt, C. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12757 · Cited by 38
Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives
Giuliani, D., Ottani, A., Neri, L., Zaffe, D., Grieco, P., Jochem, J., Cavallini, G. M., Catania, A., & Guarini, S. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.004 · Cited by 38
Epigenetic regulation in Huntington's disease
Hyeon, J. W., Kim, A. H., & Yano, H. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105074 · Cited by 40
TIP60 in aging and neurodegeneration
Li, Z., & Rasmussen, L. J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101195 · Cited by 37
Neuroepigenetics of Aging and Age-Related Neurodegenerative Disorders
Lardenoije, R., Pishva, E., Lunnon, K., & van den Hove, D. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.04.008 · Cited by 37
Self-citation
Post-translational histone modifications and their interaction with sex influence normal brain development and elaboration of neuropsychiatric disorders
Singh, G., Singh, V., & Schneider, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.016 · Cited by 38
Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1
Wang, R., Wu, Y., Liu, R., Liu, M., Li, Q., Ba, Y., & Huang, H. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02187-2 · Cited by 38
Counteracting aged DNA methylation states to combat ageing and age-related diseases
Reale, A., Tagliatesta, S., Zardo, G., & Zampieri, M. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111695 · Cited by 42
Promoter DNA hypermethylation – Implications for Alzheimer’s disease
Liu, Y., Wang, M., Marcora, E. M., Zhang, B., & Goate, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134403 · Cited by 37
DNA Methyltransferase 1 (DNMT1) Function Is Implicated in the Age-Related Loss of Cortical Interneurons
Hahn, A., Bayer, C., Pensold, D., Tittelmeier, J., Marx-Blümel, L., González-Bermúdez, L., Linde, J., Groß, J., Salinas, G., Lingner, T., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00639 · Cited by 36
Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex
Petrozziello, T., Mills, A. N., Vaine, C. A., Penney, E. B., Fernandez‐Cerado, C., Legarda, G. P., Velasco-Andrada, M. S., Acuña, P. J., Ang, M. A. C., Muñoz, E. L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105032 · Cited by 35
Epigenetic Modifications Associated with Maternal Anxiety during Pregnancy and Children’s Behavioral Measures
Cao-Lei, L., van den Heuvel, M. I., Huse, K., Platzer, M., Elgbeili, G., Braeken, M. A. K. A., Otte, R. A., Witte, O. W., Schwab, M. G., & den Bergh, B. R. H. V. (2021) · Cells · doi:10.3390/cells10092421 · Cited by 36
Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases
Dorostgou, Z., Yadegar, N., Dorostgou, Z., Khorvash, F., & Vakili, O. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25094 · Cited by 35
DNA methylation in Huntington’s disease: Implications for transgenerational effects
Thomas, E. A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.10.060 · Cited by 36
Targeting epigenetic modifications in Parkinson's disease therapy
Zhang, D., Zhang, J., Wang, Y., Wang, G., Tang, P., Liu, Y., Zhang, Y., & Ouyang, L. (2023) · Medicinal Research Reviews · doi:10.1002/med.21962 · Cited by 36
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer’s disease
Li, Y., Lin, S., Gu, Z., Chen, L., & He, B. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.129015 · Cited by 34
OPRK1 promoter hypermethylation increases the risk of Alzheimer’s disease
Ji, H., Wang, Y., Liu, G., Xu, X., Dai, D., Chen, Z., Zhou, D., Zhou, X., Han, L., Li, Y., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.027 · Cited by 33
Guideline No. 454: Identification and Treatment of Perinatal Mood and Anxiety Disorders
Shea, A. K., Jumah, N. A., Forte, M., Cantin, C. M., Bayrampour, H., Butler, K., Francoeur, D., Green, C., & Cook, J. L. (2024) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2024.102696 · Cited by 40
Epigenetic Mechanisms in Aging: Extrinsic Factors and Gut Microbiome
Borrego-Ruiz, A., & Borrego, J. J. (2024) · Genes · doi:10.3390/genes15121599 · Cited by 34
Mitochondrial DNA and Neurodegeneration: Any Role for Dietary Antioxidants?
Bordoni, L., & Gabbianelli, R. (2020) · Antioxidants · doi:10.3390/antiox9080764 · Cited by 32
Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases
Beaver, M., Bhatnagar, A., Panikker, P., Zhang, H., Snook, R., Parmar, V., Vijayakumar, G., Betini, N., Akhter, S., & Elefant, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-75035-3 · Cited by 33
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Štrac, D. Š., Konjevod, M., Šagud, M., Perković, M. N., Erjavec, G. N., Vuić, B., Šimić, G., Vukić, V., Mimica, N., & Pivac, N. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s284615 · Cited by 30
Role of Exosomes in Parkinson’s and Alzheimer’s Diseases
Sharma, H., Tyagi, S. J., Chandra, P., Verma, A. K., Kumar, P., Ashique, S., & Hussain, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-8373-5_6 · Cited by 34
Targeted DNA methylation of neurodegenerative disease genes via homology directed repair
Cali, C. P., Park, D. S., & Lee, E. B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz979 · Cited by 28
Cross‐Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer’s Disease and Huntington’s Disease
Liu, L., Bai, J., Liu, F., Xu, Y., Zhao, M., Zhao, C., & Zhou, Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7619255 · Cited by 31
Identification and Structure–Activity Relationship Studies of Small‐Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1
Robaa, D., Wagner, T., Luise, C., Carlino, L., McMillan, J., Flaig, R., Schüle, R., Jung, M., & Sippl, W. (2016) · ChemMedChem · doi:10.1002/cmdc.201600362 · Cited by 29
Regulation of neuronal survival by DNA methyltransferases
Zimmer‐Bensch, G., & Symmank, J. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.219027 · Cited by 31
A Single Prior Injection of Methamphetamine Enhances Methamphetamine Self-Administration (SA) and Blocks SA-Induced Changes in DNA Methylation and mRNA Expression of Potassium Channels in the Rat Nucleus Accumbens
Jayanthi, S., Torres, O. V., Ladenheim, B., & Cadet, J. L. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01830-3 · Cited by 29
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
Yazar, V., Dawson, V. L., Dawson, T. M., & Kang, S.-U. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-223517 · Cited by 29
Directing neuronal cell fate in vitro: Achievements and challenges
Riemens, R. J. M., van den Hove, D., Esteller, M., & Delgado‐Morales, R. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.003 · Cited by 27
DNA Methyltransferase 1 Is Dysregulated in Parkinson’s Disease via Mediation of miR-17
Zhang, H.-Q., Wang, J., Li, Z.-F., Cui, L., Huang, S., Zhu, L.-B., Sun, Y., Yang, R., Fan, H.-H., Zhang, X., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02298-w · Cited by 30
Nuclear dynamics and stress responses in Alzheimer’s disease
Iatrou, A., Clark, E. M., & Wang, Y. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00489-6 · Cited by 31
Self-citation
DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer’s, Related Tauopathies and Genetic Tauopathies
Zimmer‐Bensch, G., & Zempel, H. (2021) · Cells · doi:10.3390/cells10113064 · Cited by 33
Neuroepigenetics of ageing and neurodegeneration-associated dementia: An updated review
Mir, F. A., Amanullah, A., Jain, B. P., Hyderi, Z., & Gautam, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102067 · Cited by 30
G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease
Bellver‐Sanchís, A., Geng, Q., Navarro, G., Ávila-López, P. A., Companys‐Alemany, J., Marsal-García, L., Larramona‐Arcas, R., Miró, L., Pérez‐Bosque, A., Ortuño‐Sahagún, D., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.0424-2 · Cited by 26
Organelle aging: Lessons from model organisms
Bouska, M. J., Huang, K., Kang, P., & Bai, H. (2019) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.03.011 · Cited by 27
Epigenetic enzymes: A role in aging and prospects for pharmacological targeting
PASYUKOVA, E. G., Symonenko, A. V., Rybina, O. Y., & Vaiserman, A. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101312 · Cited by 28
Gut brain regulation using psychobiotics for improved neuropsychological illness
Deepika, Shukla, A. K., Kumari, A., & Kumar, A. (2023) · Developmental Psychobiology · doi:10.1002/dev.22404 · Cited by 28
The Transcription Factor XBP1 in Memory and Cognition: implications in Alzheimer’s Disease
Cissé, M., Duplan, E., & Checler, F. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00229 · Cited by 28
Genetic Insights Into Frailty: Association of 9p21-23 Locus With Frailty
Sathyan, S., Barzilai, N., Atzmon, G., Milman, S., Ayers, E. I., & Verghese, J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00105 · Cited by 28
Alteration of the brain methylation landscape following postnatal inflammatory injury in rat pups
Pierre, W. C., Legault, L., Londoño, I., McGraw, S., & Lodygensky, G. A. (2019) · The FASEB Journal · doi:10.1096/fj.201901461r · Cited by 25
Hypermethylation of the Gene Coding for PGC-1α in Peripheral Blood Leukocytes of Patients With Parkinson’s Disease
Yang, X., Xu, S., Qian, Y., He, X., Chen, S., & Xiao, Q. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00097 · Cited by 26
Neurodegeneration caused by S1P-lyase deficiency involves calcium-dependent tau pathology and abnormal histone acetylation
Alam, S., Piazzesi, A., Abd El Fatah, M., Raucamp, M., & van Echten-Deckert, G. (2020) · Cells · doi:10.3390/cells9102189 · Cited by 26
Knock-Down of HDAC2 in Human Induced Pluripotent Stem Cell Derived Neurons Improves Neuronal Mitochondrial Dynamics, Neuronal Maturation and Reduces Amyloid Beta Peptides
Frankowski, H., Yeboah, F., Berry, B. J., Kinoshita, C., Lee, M., Evitts, K. M., Davis, J., Kinoshita, Y., Morrison, R. S., & Young, J. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052526 · Cited by 26
Epigenetic Drug Repositioning for Alzheimer’s Disease Based on Epigenetic Targets in Human Interactome
Chatterjee, P., Roy, D., & Rathi, N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161104 · Cited by 25
Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson’s Disease Data
Mariani, E., Lombardini, L., Facchin, F., Pizzetti, F., Frabetti, F., Tarozzi, A., & Casadei, R. (2018) · Genes · doi:10.3390/genes9060275 · Cited by 25
Dual BET/HDAC inhibition to relieve neuropathic pain: Recent advances, perspectives, and future opportunities
Romanelli, M. N., Borgonetti, V., & Galeotti, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105901 · Cited by 25
Unlocking the Epigenetic Symphony: Histone Acetylation’s Impact on Neurobehavioral Change in Neurodegenerative Disorders
Basavarajappa, B. S., & Subbanna, S. (2024) · Epigenomics · doi:10.2217/epi-2023-0428 · Cited by 24
Neuroprotection with Natural Antioxidants and Nutraceuticals in the Context of Brain Cell Degeneration: The Epigenetic Connection
Carrera, I., Martínez, O., & Cacabelos, R. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191202155738 · Cited by 25
Preventive electroacupuncture reduces cognitive deficits in a rat model of D-galactose-induced aging
Yu, C.-C., He, C., Du, Y.-J., Gao, S., Lin, Y.-F., Wang, S.-Q., Wang, S., Wang, J., Wang, J., Jiang, T., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.297090 · Cited by 23
The tumor suppression theory of aging
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111583 · Cited by 27
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives
Hernaiz, A., Toivonen, J. M., Bolea, R., & Martín‐Burriel, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012609 · Cited by 26
Involvement of lncRNA TUG1 in HIV-1 Tat-Induced Astrocyte Senescence
Pillai, P. P., Kannan, M., Sil, S., Singh, S., Thangaraj, A., Chivero, E. T., Dagur, R. S., Tripathi, A., Hu, G., Periyasamy, P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054330 · Cited by 24
DNA Methyltransferase 1 (DNMT1) Acts on Neurodegeneration by Modulating Proteostasis-Relevant Intracellular Processes
Bayer, C., Pitschelatow, G., Hannemann, N., Linde, J., Reichard, J., Pensold, D., & Zimmer‐Bensch, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155420 · Cited by 25
Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseasePreprint
Rahman, M. R., Islam, T., Shahjaman, M., Quinn, J. M. W., Holsinger, R. M. D., & Moni, M. A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/482828 · Cited by 24
Brain resident microglia in Alzheimer’s disease: foe or friends
Kaur, S., Malleshwari, K., Sharma, A., Giridharan, V. V., & Dandekar, M. P. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01550-8 · Cited by 23
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 30
Potential Therapeutic Approaches to Alzheimer’s Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools
Avram, S., Mernea, M., Limban, C., Borcan, F., & Chifiriuc, M. C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x18666191230120053 · Cited by 24
Mitochondrial polymerase gamma dysfunction and aging cause cardiac nuclear DNA methylation changes
Koczor, C. A., Ludlow, I., Fields, E. J., Jiao, Z., Ludaway, T., Russ, R. B., & Lewis, W. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00099.2015 · Cited by 23
DNA Methylation Profiles in Whole Blood of Huntington's Disease Patients
Zadel, M., Maver, A., Kovanda, A., & Peterlin, B. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00655 · Cited by 23
Epigenetic regulation in the pathophysiology of Lewy body dementia
Chouliaras, L., Kumar, G. S., Thomas, A. J., Lunnon, K., Chinnery, P. F., & O'Brien, J. T. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101822 · Cited by 24
Epigenetic Modifications of the α‐Synuclein Gene and Relative Protein Content Are Affected by Ageing and Physical Exercise in Blood from Healthy Subjects
Daniele, S., Costa, B., Pietrobono, D., Giacomelli, C., Iofrida, C., Trincavelli, M. L., Fusi, J., Franzoni, F., & Martini, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3740345 · Cited by 22
Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of α-synuclein in experimental Parkinson's disease models
Srivastava, A. K., Choudhury, S. R., & Karmakar, S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108372 · Cited by 21
SNCA Gene Methylation in Parkinson’s Disease and Multiple System Atrophy
Fedotova, E. Y., Iakovenko, E. V., Abramycheva, N. Y., & Illarioshkin, S. N. (2023) · Epigenomes · doi:10.3390/epigenomes7010005 · Cited by 21
Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer’s disease: looking in the correct place at the right time?
Iatrou, A., Kenis, G., Rutten, B. P. F., Lunnon, K., & van den Hove, D. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2361-4 · Cited by 22
Self-citation
Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease: Challenges and research opportunities
Rungratanawanich, W., Ballway, J. W., Wang, X., Won, K., Hardwick, J. P., & Song, B. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108547 · Cited by 22
Genome-wide study reveals novel roles for formin-2 in axon regeneration as a microtubule dynamics regulator and therapeutic target for nerve repair
Au, N. P. B., Wu, T., Chen, X., Gao, F., Li, Y. Y. T., Tam, W. Y., Yu, K. N., Geschwind, D. H., Coppola, G., Wang, X., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.11.011 · Cited by 20
Systematic Review of Epigenetic Effects of Pharmacological Agents for Bipolar Disorders
Lockwood, L. E., & Youssef, N. A. (2017) · Brain Sciences · doi:10.3390/brainsci7110154 · Cited by 20
AMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets
Ning, L., Shen, R., Xie, B., Jiang, Y., Geng, X., & Dong, W. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae093 · Cited by 19
Age-dependent effects of a high-fat diet combined with dietary advanced glycation end products on cognitive function and protection with voluntary exercise
Luo, L., Li, R., Wang, G., Chen, J., Chen, L., Qin, L., Yu, Z., & Wan, Z. (2022) · Food & Function · doi:10.1039/d1fo03241k · Cited by 19
Age-related Loss of miR-124 Causes Cognitive Deficits via Derepressing RyR3 Expression
Liu, K., Yin, Y., Le, Y., Ouyang, W., Pan, A., Huang, J., Xie, Z., Zhu, Q., & Tong, J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0204 · Cited by 19
Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
Kumar, A., Emdad, L., Fisher, P. B., & Das, S. K. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.01.001 · Cited by 20
DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer’s disease
Daily, K. P., Badr, A., Eltobgy, M. M., Estfanous, S. Z. K., Whitham, O. D., Tan, M. H., Carafice, C., Krause, K., McNamara, A. J., Hamilton, K., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01390-2 · Cited by 24
DNA methylation level of the neprilysin promoter in Alzheimer's disease brains
Nagata, K., Mano, T., Murayama, S., Saido, T. C., & Iwata, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.01.003 · Cited by 19
The Diathesis–Epilepsy Model: How Past Events Impact the Development of Epilepsy and ComorbiditiesPreprint
Bernard, C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022418 · Cited by 19
Principles of brain aging: Status and challenges of modeling human molecular changes in mice
Kluever, V., & Fornasiero, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101465 · Cited by 18
Age-Associated DNA Methylation Patterns Are Shared Between the Hippocampus and Peripheral Blood Cells
Harris, C. J., Davis, B. A., Zweig, J. A., Nevonen, K. A., Quinn, J. F., Carbone, L., & Gray, N. E. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00111 · Cited by 19
Whole-Genome Bisulfite Sequencing Using the Ovation® Ultralow Methyl-Seq Protocol
Daviaud, C., Renault, V., Mauger, F., Deleuze, J., & Tost, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7481-8_5 · Cited by 20
Altered Regulation of KIAA0566, and Katanin Signaling Expression in the Locus Coeruleus With Neurofibrillary Tangle Pathology
Andrés‐Benito, P., Delgado‐Morales, R., & Ferrer, I. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00131 · Cited by 18
Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa?
Sild, M., & Booij, L. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0366-8 · Cited by 19
Inhibition of Histone Methyltransferases EHMT1/2 Reverses Amyloid-β-Induced Loss of AMPAR Currents in Human Stem Cell-Derived Cortical Neurons
Lin, L., Liu, A., Li, H., Feng, J., & Yan, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190190 · Cited by 18
Dysregulation of the secretory pathway connects Alzheimer’s disease genetics to aggregate formation
Kuo, C., Chiang, A. W. T., Baghdassarian, H., & Lewis, N. E. (2021) · Cell Systems · doi:10.1016/j.cels.2021.06.001 · Cited by 19
Circular RNAs in Parkinson’s Disease: Reliable Biological Markers and Targets for Rehabilitation
Duan, Y., Wang, Y., Liu, Y., Jin, Z., Liu, C., Yu, X., Chen, K., Meng, D., Xi, J., & Fang, B. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03268-0 · Cited by 17
Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease
Ilina, A., Khavinson, V., Linkova, N. S., & Petukhov, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084259 · Cited by 18
Epigenetic Metalloenzymes
Blanquart, C., Linot, C., Cartron, P., Tomaselli, D., Mai, A., & Bertrand, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180706105903 · Cited by 17
Marked Mild Cognitive Deficits in Humanized Mouse Model of Alzheimer’s-Type Tau Pathology
Cho, J. D., Kim, Y. A., Rafikian, E. E., Yang, M., & Santa‐María, I. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.634157 · Cited by 15
Neuroprotective effects of some epigenetic modifying drugs’ on Chlamydia pneumoniae-induced neuroinflammation: A novel model
Tilki, E. K., & Dikmen, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260633 · Cited by 16
From genome to epigenome: Who is a predominant player in the molecular hallmarks determining epigenetic mechanisms underlying ontogenesis?
Samiec, M., & Trzcińska, M. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100965 · Cited by 16
Neuroimaging Studies Illustrate the Commonalities Between Ageing and Brain Diseases
Cole, J. H. (2018) · BioEssays · doi:10.1002/bies.201700221 · Cited by 18
Dietary restriction regimens for fighting kidney disease: Insights from rodent studies
Singh, G., & Krishan, P. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110738 · Cited by 16
In vivo tissue-specific chromatin profiling in Drosophila melanogaster using GFP-tagged nuclei
Jauregui-Lozano, J. P. P., Bakhle, K. M., & Weake, V. M. (2021) · Genetics · doi:10.1093/genetics/iyab079 · Cited by 16
Stochastic Epigenetic Mutations Influence Parkinson’s Disease Risk, Progression, and Mortality
Chen, G. K., Yan, Q. J., Paul, K. C., Kusters, C., Folle, A. D., Furlong, M., Keener, A. M., Bronstein, J. M., Horvath, S., & Ritz, B. R. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212834 · Cited by 15

Authors: Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., & Rutten, B. P. F.
Affiliations: Maastricht University (NL)
University of Lausanne (CH)
Banner Sun Health Research Institute (US)
Brigham and Women's Hospital (US)
Icahn School of Medicine at Mount Sinai (US)
Corresponding author: Rutten, Bart P.F.
ORCID: Lardenoije, Roy
Iatrou, Artemis
Kompotis, Konstantinos
Steinbusch, Harry W.M.
Mastroeni, Diego
Coleman, Paul
Lemere, Cynthia A.
Hof, Patrick R.
Rutten, Bart P.F.
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2015-08
Volume: 131
Pages: 21-64
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2015.05.002
PMC: PMC6477921
OpenAlex: W648684004
Cited by: 381
References: 770
Citations by year: 2026: 12 · 2025: 29 · 2024: 28 · 2023: 28 · 2022: 32 · 2021: 47 · 2020: 30 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 11
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Research Publications (Maastricht University) (submittedVersion)
Funders: Internationale Stichting Alzheimer Onderzoek (07551, 11532, 09552, 13515)
Netherlands Organization for Scientific Research (916.11.086)
National Institutes of Health (P50 AG005138)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: epigenetics, aging, neurodegeneration, DNA methylation, DNA demethylation, chromatin remodeling, non-coding RNA, Alzheimer's disease, Parkinson's disease, Huntington's disease, epigenetic therapy, gene expression regulation, histone modifications
MeSH terms: Aging, Animals, Humans, DNA Methylation, Neurodegenerative Diseases, Genetic Predisposition to Disease, RNA, Untranslated, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The epigenetics of aging and neurodegeneration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks